Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 03:22 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor Induction
NCT01190163 · Ferring Pharmaceuticals · PHASE4 · terminated · last registry update 2012-08-23 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “Study was early terminated due to problems enrolling adequate number of patients” | – | Registry record, Ferring Pharmaceuticals |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTGER1 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2013-02-28Phase 3 first posted: University of Liverpool, Misoprostol (NCT01801410)
- 2013-02-21Results posted on the registry: Shirley Ryan AbilityLab, Lubiprostone + Senna (NCT00662363)
- 2012-11-30Results posted on the registry: Brooke Army Medical Center, Miralax (PEG 3350) + Amitiza (Lubiprostone) (NCT00953017)
- 2012-11-01Results posted on the registry: Brooke Army Medical Center, lubiprostone + placebo (NCT00611442)
- 2012-10-04Results posted on the registry: Ain Shams University, Propess + Prostin E2 (NCT01635439)
- 2012-08-29Phase 3 first posted: Dr. Reddy's Laboratories Limited, India, Lubiprostone + Lubiprostone (NCT01674530)
- 2012-07-09Phase 3 first posted: Ain Shams University, Propess + Prostin E2 (NCT01635439)
- 2012-06-29Results posted on the registry: UCB Pharma, Alprostadil (Prostaglandin E1) + Pentoxifylline (NCT01263925)
- 2012-05-15Results posted on the registry: University of Arkansas, Lubiprostone (NCT00669461)
- 2012-03-28Results posted on the registry: Pfizer, a drug against PTGER1 (NCT01008605)
- 2012-02-09Results posted on the registry: Mayo Clinic, lubiprostone + Placebo (NCT00953043)
- 2011-12-12Results posted on the registry: Cedars-Sinai Medical Center, Lubiprostone + Placebo (NCT01085643)
- 2011-11-10Phase 3 first posted: Texas Tech University Health Sciences Center, El Paso, Lubiprostone (NCT01469819)
- 2011-10-06Phase 3 first posted: Texas Tech University Health Sciences Center, El Paso, lubiprostone + placebo (NCT01447849)
- 2011-08-26Results posted on the registry: Frank A. Bucci, Jr., M.D., Ketorolac Tromethamine + Bromfenac (NCT01021761)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision